Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

34.86
-2.8200-7.48%
Post-market: 34.76-0.1000-0.29%19:59 EDT
Volume:5.43M
Turnover:190.50M
Market Cap:5.53B
PE:232.40
High:37.27
Open:37.27
Low:34.03
Close:37.68
Loading ...

Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers?

Insider Monkey
·
15 Jan

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise

Zacks
·
15 Jan

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last?

Zacks
·
15 Jan

Have Insiders Sold TG Therapeutics Shares Recently?

Simply Wall St.
·
15 Jan

TG Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow Jones
·
15 Jan

Strong Financial Outlook and Strategic Growth Opportunities Bolster Buy Rating for TG Therapeutics

TIPRANKS
·
15 Jan

TG Therapeutics Reports Strong Revenue and Future Goals

TIPRANKS
·
15 Jan

TG Therapeutics Inc - Sees FY 2025 Global Revenue $540 Million

THOMSON REUTERS
·
15 Jan

TG Therapeutics Shares Climb 7% as Sales Grow for Multiple Sclerosis Drug

Dow Jones
·
15 Jan

Why TGTX Stock Is Rallying Today

Insider Monkey
·
15 Jan

B.Riley Financial Reaffirms Their Buy Rating on TG Therapeutics (TGTX)

TIPRANKS
·
14 Jan

TG Therapeutics Provides Q4 Briumvi Revenue Guidance; Sets 2025 Total Revenue Outlook; Shares Rise Pre-Bell

MT Newswires Live
·
14 Jan

BUZZ-TG Therapeutics rises after preliminary Q4 net product revenue tops estimates

Reuters
·
14 Jan

TG Therapeutics sees Q4 BRIUMVI U.S. net product revenue $103.6M

TIPRANKS
·
14 Jan

TG Therapeutics targets FY25 global revenue $540M, consensus $537.84M

TIPRANKS
·
14 Jan

TG Therapeutics Inc FY2025 REV View $549.5 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
14 Jan

TG Therapeutics Inc Outlook FY 2025 Target Total Global Revenue of About $540 Million

THOMSON REUTERS
·
14 Jan

TG Therapeutics Inc Qtrly Briumvi U.S. Net Product REV Expected to Be $103.6 Mln

THOMSON REUTERS
·
14 Jan

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

THOMSON REUTERS
·
14 Jan

Should You Invest in TG Therapeutics (TGTX)?

Insider Monkey
·
10 Jan